世界の血友病市場は、2024年から2028年の間に5.81%のCAGRで成長し、2028年には177億6,000万ドルに達すると予想されます。市場の成長は、医療費の増加、特定された血友病患者数の急増、予防的治療への関心の高まり、男性人口の増加、政府の有利な取り組みなどの要因によって推進されています。市場は、治療費の高さや新しい治療法への切り替えへの消極性など、特定の課題に直面することが予想されます。これらの課題を克服するために、市場は新しい血友病治療薬の開発や遺伝子治療の人気の高まりなど、いくつかの重要な動向が見られるでしょう。
世界の血友病市場は、治療レジメン別に、予防とオンデマンドに分けることができます。2023年は、予防セグメントがより高いシェアを占め、次いでオンデマンドセグメントが続きました。世界の血友病市場は、タイプ別に血友病Aと血友病Bに分類され、2023年には血友病Aがより大きなシェアを占めました。世界の血友病市場は、補充療法とITI療法に分類できます。2023年には補充療法のセグメントが支配的なシェアを保持しました。
世界の血友病市場は地域別に北米、ヨーロッパ、アジア太平洋の地域に分割できます。2023年には、北米が市場の大部分を占め、ヨーロッパとアジア太平洋がそれに続きました。血友病の有病率の上昇、さまざまな治療法に関する個人の知識の向上、予防治療への傾向の急増などの要因が、北米市場の成長に貢献しました。
目次
Table of contents
1. Market Overview
1.1 Hemophilia
1.2 Types of Hemophilia
1.3 Signs & Symptoms
1.4 Diagnosis of Hemophilia
1.5 Treatment of Hemophilia
2. Impact of COVID-19
2.1 Impact on Global Economy
2.2 Global Prevalence of COVID-19
2.3 Impact on Healthcare Spending
2.4 Post-COVID Scenario
3. Global Market Analysis
3.1 Global Hemophilia Market by Value
3.2 Global Hemophilia Market Forecast by Value
3.3 Global Hemophilia Market by Treatment Regimen
3.4 Global Hemophilia Market by Type
3.4.1 Global Hemophilia A Market Forecast by Value
3.4.2 Global Hemophilia A Market by Severity
3.4.3 Global Hemophilia A Market by Treatment Type
3.4.4 Global Hemophilia A Market by Treatment Regimen
3.4.5 Global Hemophilia A Market Value by Treatment Regimen
3.4.6 Global Hemophilia B Market Forecast by Value
3.4.7 Global Hemophilia B Market by Severity
3.4.8 Global Hemophilia B Market by Treatment Type
3.4.9 Global Hemophilia B Market by Treatment Regimen
3.4.10 Global Hemophilia B Market Value by Treatment Regimen
3.5 Global Hemophilia Market by Therapy
3.5.1 Global Hemophilia Replacement Therapy Market Forecast by Value
3.5.2 Global Hemophilia ITI Therapy Market Forecast by Value
3.6 Global Hemophilia Market by Region
4. Regional Market Analysis
4.1 North America
4.1.1 North America Hemophilia Market by Value
4.1.2 North America Hemophilia Market Forecast by Value
4.1.3 The US Hemophilia Market by Value
4.1.4 The US Hemophilia Market Forecast by Value
4.1.5 The US Hemophilia Market by Type
4.1.6 The US Hemophilia A Market Forecast by Value
4.1.7 The US Hemophilia A Treated Patient Volume Forecast
4.1.8 The US Hemophilia A Severe Patients on Prophylactic Therapy
4.1.9 The US Hemophilia A Severe Patients on On-Demand Therapy
4.1.10 The US Hemophilia A Mild to Moderate Patients on Prophylaxis Therapy
4.1.11 The US Hemophilia A Mild to Moderate Patients on On-Demand Therapy
4.1.12 The US Hemophilia B Market Forecast by Value
4.1.13 The US Hemophilia B Treated Patients Volume Forecast
4.1.14 The US Hemophilia B Severe Patients on Prophylaxis Therapy
4.1.15 The US Hemophilia B Severe Patients on On-Demand Therapy
4.1.16 The US Hemophilia B Mild to Moderate Patients on Prophylaxis Therapy
4.1.17 The US Hemophilia B Mild to Moderate Patients on On-Demand Therapy
4.2 Europe
4.2.1 Europe Hemophilia Market by Value
4.2.2 Europe Hemophilia Market Forecast by Value
4.2.3 Europe Hemophilia Patient Volume Forecast
4.2.4 Europe Hemophilia A Patient Volume Forecast
4.2.5 Europe Hemophilia B Patient Volume Forecast
4.3 Asia Pacific
4.3.1 Asia Pacific Hemophilia Market by Value
4.3.2 Asia Pacific Hemophilia Market Forecast by Value
4.4 ROW
4.4.1 ROW Hemophilia Market by Value
4.4.2 ROW Hemophilia Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increased Focus on Prophylactic Treatment
5.1.2 Increasing Diagnosis Rate
5.1.3 Rise in Global Healthcare Expenditure
5.1.4 Rise in Male Population
5.1.5 Favourable Government Initiatives
5.2 Key Trends & Development
5.2.1 Shifting Focus to Extended Half Life Therapies
5.2.2 Development of Novel Hemophilia Treatments
5.2.3 Popularity of Gene Therapy
5.3 Challenges
5.3.1 High Cost of Treatment
5.3.2 Reluctance to Switch to New Therapies
6. Competitive Landscape
6.1 Global Market
6.1.1 Global Hemophilia A Market Share by Company
6.1.2 Global Hemophilia A Factor VIII Products Market Share by Company
6.1.3 Global Hemophilia A FVIII Gene Therapy Market Share Forecast
6.1.4 Global Hemophilia B Market Share by Company
6.1.5 Global Hemophilia B Factor IX Products Market Share Forecast
6.1.6 Global Hemophilia B Factor IX Gene Therapy Market Share Forecast
6.2 The US Market
6.2.1 The US Hemophilia A Market Share by Company
6.3 Europe Market
6.3.1 Europe Hemophilia A Market Share by Company
7. Company Profiles
7.1 Pfizer Inc.
7.1.1 Business Overview
7.2 Bayer Group
7.2.1 Business Overview
7.3 Sanofi S.A.
7.3.1 Business Overview
7.4 Takeda Pharmaceutical Company
7.4.1 Business Overview
7.5 Novo Nordisk
7.5.1 Business Overview
7.6 CSL Limited
7.6.1 Business Overview
List of Figures
Types of Hemophilia
Diagnosis of Hemophilia
Global Coronavirus Prevalence (May’21 - Dec’21)
Global Hemophilia Market by Value (2019-2023)
Global Hemophilia Market Forecast by Value (2024-2028)
Global Hemophilia Market by Treatment Regimen (2023)
Global Hemophilia Market by Type (2023)
Global Hemophilia A Market Forecast by Value (2020-2028)
Global Hemophilia A Market by Severity (2023)
Global Hemophilia A Market by Treatment Type (2023)
Global Hemophilia A Market by Treatment Regimen (2023 & 2028)
Global Hemophilia A Market Value by Treatment Regimen (2020-2028)
Global Hemophilia B Market Forecast by Value (2020-2028)
Global Hemophilia B Market by Severity (2023)
Global Hemophilia B Market by Treatment Type (2023)
Global Hemophilia B Market by Treatment Regimen (2023 & 2028)
Global Hemophilia B Market Value by Treatment Regimen (2020-2028)
Global Hemophilia Market by Therapy (2023)
Global Hemophilia Replacement Therapy Market Forecast by Value (2020-2028)
Global Hemophilia ITI Therapy Market Forecast by Value (2020-2028)
Global Hemophilia Market by Region (2023)
North America Hemophilia Market by Value (2019-2023)
North America Hemophilia Market Forecast by Value (2024-2028)
The US Hemophilia Market by Value (2019-2023)
The US Hemophilia Market Forecast by Value (2024-2028)
The US Hemophilia Market by Type (2023)
The US Hemophilia A Market Forecast by Value (2020-2028)
The US Hemophilia A Treated Patient Volume Forecast (2020-2028)
The US Hemophilia A Severe Patients on Prophylactic Therapy (2020-2028)
The US Hemophilia A Severe Patients on On-Demand Therapy (2020-2028)
The US Hemophilia A Mild to Moderate Patients on Prophylaxis Therapy (2020-2028)
The US Hemophilia A Mild to Moderate Patients on On-Demand Therapy (2020-2028)
The US Hemophilia B Market Forecast by Value (2020-2028)
The US Hemophilia B Treated Patients Volume Forecast (2020-2028)
The US Hemophilia B Severe Patients on Prophylaxis Therapy (2020-2028)
The US Hemophilia B Severe Patients on On-Demand Therapy (2020-2028)
The US Hemophilia B Mild to Moderate Patients on Prophylaxis Therapy (2020-2028)
The US Hemophilia B Mild to Moderate Patients on On-Demand Therapy (2020-2028)
Europe Hemophilia Market by Value (2019-2023)
Europe Hemophilia Market Forecast by Value (2024-2028)
Europe Hemophilia Patient Volume Forecast (2020-2028)
Europe Hemophilia A Patient Volume Forecast (2020-2028)
Europe Hemophilia B Patient Volume Forecast (2020-2028)
Asia Pacific Hemophilia Market by Value (2019-2023)
Asia Pacific Hemophilia Market Forecast by Value (2024-2028)
ROW Hemophilia Market by Value (2019-2023)
ROW Hemophilia Market Forecast by Value (2024-2028)
Global Market Share of Hemophilia A and B Patients on Prophylaxis (2019 & 2024)
Global Identified Hemophilia Patients Volume (2019-2023)
Global Health Spending Per Capita (2018-2023)
Global Male Population (2016-2023)
Global Hemophilia A Market Share by Company (2023)
Global Hemophilia A Factor VIII Products Market Share by Company (2023/2030)
Global Hemophilia A FVIII Gene Therapy Market Share Forecast (2030)
Global Hemophilia B Market Share by Company (2023)
Global Hemophilia B Factor IX Products Market Share Forecast (2023/2030)
Global Hemophilia B Factor IX Gene Therapy Market Share Forecast (2030)
The US Hemophilia A Market Share by Company (2023)
Europe Hemophilia B Market Share by Company (2023)
List of Tables
Signs & Symptoms of Hemophilia
Extended Half Life Products
Development of New Novel Haemophilia Treatments
Hemophilia Gene Therapy Candidates
